eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-DBV.PA-DBV Technologies

DBV Technologies DBV.PA

€1.622-0.01(-0.49%)(1D)
• Delayed prices by Euronext Paris • in EUR
Invest in DBV Technologies
Today
Create an eToro account to buy DBV.PA stock on a secure, user-friendly, multi-asset trading platform.
Buy DBV Technologies
Buy DBV Technologies
DBV Technologies DBV.PA
Buy DBV.PA
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
6.00
Based on analysts who covered DBV.PA

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

DBV Technologies News

About DBV Technologies
DBV Technologies is headquartered in Montrouge, France and is a clinical-stage biopharmaceutical company responsible for developing Viaskin®, an investigational proprietary technology platform with potential applications in immunotherapy. The development of Viaskin® is based on epicutaneous immunotherapy, the company’s method for delivering biologically active compounds to the patient’s immune system through intact skin.

The company’s self-administered and non-invasive product candidates enable DBV Technologies to offer innovative solutions for food allergic patients. Current company programs include clinical trials and preclinical development of Viaskin Peanut, Viaskin Milk, Viaskin Egg, and other solutions.

In 2018, the company announced preliminary results from Part B of the Viaskin Milk study, reporting that a statistically significant desensitisation to milk was found in children ages two to 11 who were treated with Viaskin Milk for 12 months.

DBV Technologies operates in France and across the US. The company’s financial results for the first half of fiscal 2019 include operating income of €7.1 million. Track this instrument for more updates and news on the current DBV.PA value.
VIEW MORE   

DBV.PA Stock Price Chart

‎-6.16‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The DBV Technologies share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The DBV Technologies price today is €1.622, a ‎-0.49‎% change in the last 24 hours and ‎7.02‎% in the past week. DBV Technologies price changed by ‎130.06‎% in the past year.
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
-
Day’s Range
i
Shows the high and low prices of the day.
€1.599 - €1.649
52W Range
i
Shows the high and low prices of the last year.
€0.503 - €2.361
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
-
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-
Revenue
i
The total income generated by this company’s goods and services last year.
-
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
-
Prev Close
i
The final price of this asset at the end of the last trading day.
€1.622
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
-
What Is DBV Technologies?
DBV Technologies is headquartered in Montrouge, France and is a clinical-stage biopharmaceutical company responsible for developing Viaskin®, an investigational proprietary technology platform with potential applications in immunotherapy. The development of Viaskin® is based on epicutaneous immunotherapy, the company’s method for delivering biologically active compounds to the patient’s immune system through intact skin.

The company’s self-administered and non-invasive product candidates enable DBV Technologies to offer innovative solutions for food allergic patients. Current company programs include clinical trials and preclinical development of Viaskin Peanut, Viaskin Milk, Viaskin Egg, and other solutions.

In 2018, the company announced preliminary results from Part B of the Viaskin Milk study, reporting that a statistically significant desensitisation to milk was found in children ages two to 11 who were treated with Viaskin Milk for 12 months.

DBV Technologies operates in France and across the US. The company’s financial results for the first half of fiscal 2019 include operating income of €7.1 million. Track this instrument for more updates and news on the current DBV.PA value.
CEO
Daniel Tassé
Employees
109
Founded
2002
HQ
Chatillon, Hauts-de-France, FR
Med Tech
Paris
Buy DBV.PA

How can I buy DBV Technologies stocks?

To purchase DBV Technologies:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the DBV Technologies (DBV.PA) page and place an order to buy DBV Technologies.
Buy DBV.PA
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy DBV Technologies
Invest in DBV Technologies
Today
Create an eToro account to buy DBV.PA stock on a secure, user-friendly, multi-asset trading platform.
Buy DBV.PA

FAQ

The current price of DBV.PA is €1.622.
The average price target for DBV Technologies is €6.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for DBV Technologies based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of DBV Technologies is -
Based on 1 analysts offering recommendations for DBV.PA in the last 3 months, the overall consensus is Moderate Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top